Beijing Medicon Pharmaceutical Technology

Beijing Medicon Pharmaceutical Technology is a prominent Chinese Contract Research Organization (CRO) that provides comprehensive clinical research services to the global pharmaceutical and biotechnology industries. Established in 2005 and headquartered in Beijing, the company specializes in clinical trial management, regulatory affairs, data management, and biostatistics. In 2014, Medicon was acquired by Hangzhou Tigermed Consulting, significantly expanding its service capabilities and geographic reach. The firm is particularly noted for its deep expertise in navigating China's regulatory environment and the National Medical Products Administration (NMPA) requirements. Medicon supports a wide range of therapeutic areas, helping clients accelerate the development and commercialization of innovative drugs and medical devices.